NGS
NGS
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$58K
Insider Sales
0
$0
Total Volume
$58K
1 transactions
Net Activity
+$58K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Jackson John Earl
Dir
$58K total
Quick Actions
NGS has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. NGS ranks #490 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at NGS (NGS) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $58K.
The net insider activity for NGS shows a net buying bias of $58K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Jackson John Earl (Dir), who traded 2.0K shares valued at $58K on Nov 13, 2026.
Is Natural Gas Services Group (NGS) Outperforming Other Oils-Energy Stocks This Year?
CEO Justin Jacobs buys Natural Gas Services Group (NGS) shares at an average $28.602 each.
Natural Gas Services Group Continues To Impress
Natural Gas Services Group (NYSE:NGS) Stock: Insider Justin Jacobs Purchases 3,000 Shares
NGS - Natural Gas Services Group Inc Stock Price and Quote
$NGS stock is down 8% today. Here's what we see in our data.
Related News & Analyst Reports
Read original insights and educational research covering NGS and the Unknown sector.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
Lock-up Expiration Frontrunning: How Venture Funds Manage Large Block Trades
When lock-up periods expire, venture funds use block trades, 10b-18 programs, and coordinated secondary offerings to exit large positions. This report reveals the strategies that minimize price impact, and how retail investors can track them.
Deciphering Form 5 Filings: Uncovering Annual Insider Gift Trades
A comprehensive guide to SEC Form 5 filings, explaining how annual reports of gift shares, stock options, and non-open-market transactions signal insider sentiment.
The Impact of Interest Rates on Insider Behavior: A Macro Analysis
When the Fed tightens, equity valuations fall, but insider purchase activity does not always follow the same pattern. This report examines three rate-hike cycles to show how rising rates affect the frequency and conviction of C-suite stock buys.
Institutional Ownership vs. Insider Trading: Understanding the Data Flow
High institutional ownership reduces information asymmetry, but does it also reduce the predictive power of insider trades? This analysis tests whether stocks with more than 70% institutional ownership show weaker Form 4 signal performance.
The Role of Venture Partners on Public Boards: Tracking a16z and Sequoia Directors
When a16z or Sequoia places a partner on a public company board, they become Section 16 insiders and must file Form 4. This report tracks VC-director trading patterns at major portfolio companies and what their transactions signal to outside investors.
FAQs About NGS Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for NGS.